Identification of distinct phenotypes related to benralizumab responsiveness in patients with severe eosinophilic asthma.

Identification of distinct phenotypes related to benralizumab responsiveness in patients with severe eosinophilic asthma.

<h4>Purpose</h4>To characterize the clinical phenotypes of severe eosinophilic asthma based on early responsiveness to benralizumab in terms of forced expiratory volume in 1 second (FEV1) improvement.<h4>Patients and methods</h4>Sixty-four participants diagnosed with severe e...

Full description

Bibliographic Details
Main Authors:	Hideyasu Yamada, Masayuki Nakajima, Masashi Matsuyama, Yuko Morishima, Naoki Arai, Norihito Hida, Taisuke Nakaizumi, Hironori Masuko, Yohei Yatagai, Takefumi Saito, Nobuyuki Hizawa
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0248305

Similar Items

An asthmatic case of psoriasiform eruption caused by administration of dupilumab
by: Takashi Matsuda, et al.
Published: (2020-07-01)

The Role of NRF2 in Mycobacterial Infection
by: Masashi Matsuyama, et al.
Published: (2021-11-01)

Risk factors for clinical progression in patients with pulmonary Mycobacterium avium complex disease without culture-positive sputum: a single-center, retrospective study
by: Mizu Nonaka, et al.
Published: (2023-06-01)

Benralizumab use in chronic eosinophilic pneumonia with eosinophilic bronchiolitis and chronic airway infection
by: Tomotsugu Takano, et al.
Published: (2021-08-01)

Early benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis
by: Stefania Colantuono, et al.
Published: (2020-07-01)

Association analyses of eQTLs of the TYRO3 gene and allergic diseases in Japanese populations
by: Jun Kanazawa, et al.
Published: (2019-01-01)

Successful Introduction of Benralizumab for Eosinophilic Ascites
by: Nabil Belfeki, et al.
Published: (2024-01-01)

Successful treatment of eosinophilic cystitis with benralizumab
by: W Donald Cooke, et al.
Published: (2020-11-01)

Rapid and remarkable effectiveness of benralizumab for treating severe bronchial asthma with intractable eosinophilic rhinosinusitis and eosinophilic otitis media: A case report
by: Hideyasu Shimizu, et al.
Published: (2021-01-01)

Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma
by: Ken Ohta, et al.
Published: (2018-04-01)

Asthma Phenotypes in Japanese Adults - Their Associations with the CCL5 ADRB2 Genotypes
by: Yoshiko Kaneko, et al.
Published: (2013-01-01)

How important is allergic sensitization as a cause of atopic asthma?
by: Jun Kanazawa, et al.
Published: (2018-04-01)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
by: Moran, AM, et al.
Published: (2020)

Benralizumab as initial treatment for chronic eosinophilic pneumonia
by: Shusuke Yazawa, et al.
Published: (2021-01-01)

Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma
by: Mirhojjat Khorasanizadeh, et al.
Published: (2017-07-01)

Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma
by: Gómez-Bastero Fernández A, et al.
Published: (2022-05-01)

Efficacy and use of benralizumab in patients with eosinophilic chronic rhinosinusitis
by: G.L. Fadda, et al.
Published: (2021-03-01)

Treatment of Widespread Eosinophilic Cellulitis (Wells’ Syndrome) with Benralizumab
by: Maria Blomberg, et al.
Published: (2020-11-01)

Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma
by: Stephen G. Noorduyn, et al.
Published: (2021-12-01)

The clinical profile of benralizumab in the management of severe eosinophilic asthma
by: Francesco Menzella, et al.
Published: (2016-12-01)

Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis
by: Hiroaki Tsurumaki, et al.
Published: (2019-07-01)

Role of Lung Function Genes in the Development of Asthma.
by: Hideyasu Yamada, et al.
Published: (2016-01-01)

A Distinct Sensitization Pattern Associated with Asthma and the Thymic Stromal Lymphopoietin (TSLP) Genotype
by: Hiroaki Iijima, et al.
Published: (2013-01-01)

Cycling therapy with benralizumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media
by: Satoshi Hamada, et al.
Published: (2021-07-01)

Genetic association of the functional CDHR3 genotype with early-onset adult asthma in Japanese populations
by: Jun Kanazawa, et al.
Published: (2017-10-01)

Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
by: Carlos Martínez-Rivera, et al.
Published: (2021-01-01)

A case of paradoxical eosinophilic fasciitis in a patient on benralizumab
by: Michael J. Woodbury, BS, et al.
Published: (2023-10-01)

Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial
by: Andrew Menzies-Gow, et al.
Published: (2019-09-01)

Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
by: Alexandra M. Nanzer, et al.
Published: (2020-11-01)

Benralizumab treatment in an elderly patient with eosinophilic esophagitis resulted in remission: a case report
by: Azusa Ishii, et al.
Published: (2024-01-01)

ROS-Nrf2 pathway mediates the development of TGF-β1-induced epithelial-mesenchymal transition through the activation of Notch signaling
by: Kai Yazaki, et al.
Published: (2021-09-01)

ORMDL3/GSDMB genotype as a risk factor for early-onset adult asthma is linked to total serum IgE levels but not to allergic sensitization
by: Haruna Kitazawa, et al.
Published: (2021-01-01)

Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma
by: Brian J Lipworth, et al.
Published: (2023-12-01)

Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases
by: Sriram Sridhar, et al.
Published: (2019-01-01)

Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
by: Andrea Portacci, et al.
Published: (2023-10-01)

Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
by: Charlene Desaintjean, et al.
Published: (2024-03-01)

Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience
by: Giulia Scioscia, et al.
Published: (2023-06-01)

Benralizumab monotherapy was insufficient to induce remission in patients with active eosinophilic granulomatosis with polyangiitis
by: Osamu Matsuno, et al.
Published: (2022-01-01)

Eosinophilic cystitis refractory to steroids successfully treated with benralizumab: A case report
by: George N. Konstantinou, et al.
Published: (2023-01-01)

Rapid and sustained effects of a single dose of benralizumab on chronic eosinophilic pneumonia
by: Takehiro Izumo, et al.
Published: (2020-01-01)